Using next-generation sequencing (NGS) technology, Archer® offers a robust platform for detecting variants associated with cancers and inherited diseases.
By using proprietary Anchored Multiplex PCR (AMP™) chemistry, Archer technology has robust detection capabilities for all variant types. Complemented by a suite of bioinformatics software, the Archer platform dramatically enhances complex variant identification and discovery.
ArcherDX, Inc. is headquartered in Boulder, Colorado.
Where ArcherDX Fits In
ArcherDX Fast Facts
45+ Countries Use Archer Panels
The ArcherDX, Inc. leadership team is dedicated to leading the transformation to personalized medicine in oncology by empowering physicians to apply high-quality genomic data in daily clinical care.